FDA Issues Warning Letter for Forest Laboratories' Bystolic Tablets

ROCK VILLE, Md., Sept. 8--The FDA posted on its web site a warning letter to Forest Laboratories, Inc. about a journal ad for its hypertension treatment Bystolic Tablets. The letter and journal ad are attached.

Posted: September 2008


View comments

Hide
(web2)